# Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2

> **NCT04729972** · PHASE2 · COMPLETED · sponsor: **Neurotech Pharmaceuticals** · enrollment: 33 (actual)

## Conditions studied

- Macular Telangiectasia Type 2

## Interventions

- **COMBINATION_PRODUCT:** NT-501 CNTF implant

## Key facts

- **NCT ID:** NCT04729972
- **Lead sponsor:** Neurotech Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-21
- **Primary completion:** 2022-12-08
- **Final completion:** 2022-12-08
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2025-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04729972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04729972, "Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04729972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*